Stephen R. Brady - Jul 3, 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
President and CEO, Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Stock symbol
TPST
Transactions as of
Jul 3, 2024
Transactions value $
$73,850
Form type
4
Date filed
7/8/2024, 04:15 PM
Previous filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPST Common Stock Purchase $73.9K +35K +307.67% $2.11 46.4K Jul 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 11,376 shares acquired under the Issuer's stock purchase plan.